Literature DB >> 22207682

Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis.

Maria Mastrogiannaki1, Pavle Matak, Jacques R R Mathieu, Stéphanie Delga, Patrick Mayeux, Sophie Vaulont, Carole Peyssonnaux.   

Abstract

BACKGROUND: Iron metabolism, regulated by the iron hormone hepcidin, and oxygen homeostasis, dependent on hypoxia-inducible factors, are strongly interconnected. We previously reported that in mice in which both liver hypoxia-inducible factors-1 and -2 are stabilized (the hepatocyte von Hippel-Lindau knockout mouse model), hepcidin expression was strongly repressed and we hypothesized that hypoxia-inducible factor-2 could be the major regulatory component contributing to the hepcidin down-regulation. DESIGN AND METHODS: We generated and analyzed hepatocyte-specific knockout mice harboring either hypoxia-inducible factor-2α deficiency (Hif2a knockout) or constitutive hypoxia-inducible factor-2α stabilization (Vhlh/Hif1a knockout) and ex vivo systems (primary hepatocyte cultures). Hif2a knockout mice were fed an iron-deficient diet for 2 months and Vhlh/Hif1a knockout mice were treated with neutralizing erythropoietin antibody.
RESULTS: We demonstrated that hypoxia-inducible factor-2 is dispensable in hepcidin gene regulation in the context of an adaptive response to iron-deficiency anemia. However, its overexpression in the double Vhlh/Hif1a hepatocyte-specific knockout mice indirectly down-regulates hepcidin expression through increased erythropoiesis and erythropoietin production. Experiments in primary hepatocytes confirmed the non-autonomous role of hypoxia-inducible factor-2 in hepcidin regulation.
CONCLUSIONS: While our results indicate that hypoxia-inducible factor-2 is not directly involved in hepcidin repression, they highlight the contribution of hepatic hypoxia-inducible factor-2 to the repression of hepcidin through erythropoietin-mediated increased erythropoiesis, a result of potential clinical interest.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207682      PMCID: PMC3366646          DOI: 10.3324/haematol.2011.056119

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  40 in total

1.  Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins.

Authors:  Stephanie McMahon; Francine Grondin; Patrick P McDonald; Darren E Richard; Claire M Dubois
Journal:  J Biol Chem       Date:  2004-12-15       Impact factor: 5.157

2.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.

Authors:  Pinelopi P Kapitsinou; Qingdu Liu; Travis L Unger; Jennifer Rha; Olena Davidoff; Brian Keith; Jonathan A Epstein; Sheri L Moores; Connie L Erickson-Miller; Volker H Haase
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

4.  Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.

Authors:  Emilio Ramos; Léon Kautz; Richard Rodriguez; Michael Hansen; Victoria Gabayan; Yelena Ginzburg; Marie-Paule Roth; Elizabeta Nemeth; Tomas Ganz
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

5.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

6.  Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project.

Authors:  Alberto Piperno; Stefania Galimberti; Raffaella Mariani; Sara Pelucchi; Giulia Ravasi; Carolina Lombardi; Grzegorz Bilo; Miriam Revera; Andrea Giuliano; Andrea Faini; Veronica Mainini; Mark Westerman; Tomas Ganz; Maria Grazia Valsecchi; Giuseppe Mancia; Gianfranco Parati
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

7.  Hepcidin in beta-thalassemia.

Authors:  Elizabeta Nemeth
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

8.  HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice.

Authors:  Maria Mastrogiannaki; Pavle Matak; Brian Keith; M Celeste Simon; Sophie Vaulont; Carole Peyssonnaux
Journal:  J Clin Invest       Date:  2009-04-06       Impact factor: 14.808

9.  High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.

Authors:  Toshihiko Tanno; Natarajan V Bhanu; Patricia A Oneal; Sung-Ho Goh; Pamela Staker; Y Terry Lee; John W Moroney; Christopher H Reed; Naomi L C Luban; Rui-Hong Wang; Thomas E Eling; Richard Childs; Tomas Ganz; Susan F Leitman; Suthat Fucharoen; Jeffery L Miller
Journal:  Nat Med       Date:  2007-08-26       Impact factor: 53.440

10.  Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli.

Authors:  Hua Huang; Marco Constante; Antonio Layoun; Manuela M Santos
Journal:  Blood       Date:  2009-02-09       Impact factor: 22.113

View more
  64 in total

Review 1.  The liver: conductor of systemic iron balance.

Authors:  Delphine Meynard; Jodie L Babitt; Herbert Y Lin
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

Review 2.  Unlocking mammalian regeneration through hypoxia inducible factor one alpha signaling.

Authors:  Kelsey G DeFrates; Daniela Franco; Ellen Heber-Katz; Phillip B Messersmith
Journal:  Biomaterials       Date:  2021-01-09       Impact factor: 12.479

Review 3.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

4.  Influence of post-exercise hypoxic exposure on hepcidin response in athletes.

Authors:  Claire E Badenhorst; Brian Dawson; Carmel Goodman; Marc Sim; Gregory R Cox; Christopher J Gore; Harold Tjalsma; Dorine W Swinkels; Peter Peeling
Journal:  Eur J Appl Physiol       Date:  2014-02-01       Impact factor: 3.078

Review 5.  Regulation of the Iron Homeostatic Hormone Hepcidin.

Authors:  Veena Sangkhae; Elizabeta Nemeth
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

Review 6.  Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2017-05-05       Impact factor: 3.905

Review 7.  Mechanisms of mammalian iron homeostasis.

Authors:  Kostas Pantopoulos; Suheel Kumar Porwal; Alan Tartakoff; L Devireddy
Journal:  Biochemistry       Date:  2012-07-09       Impact factor: 3.162

8.  Treatment of erythropoietin deficiency in mice with systemically administered siRNA.

Authors:  William Querbes; Roman L Bogorad; Javid Moslehi; Jamie Wong; Amy Y Chan; Elena Bulgakova; Satya Kuchimanchi; Akin Akinc; Kevin Fitzgerald; Victor Koteliansky; William G Kaelin
Journal:  Blood       Date:  2012-05-18       Impact factor: 22.113

Review 9.  The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.

Authors:  Kimberly Zumbrennen-Bullough; Jodie L Babitt
Journal:  Nephrol Dial Transplant       Date:  2013-11-13       Impact factor: 5.992

Review 10.  Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response.

Authors:  Matthew R Pawlus; Cheng-Jun Hu
Journal:  Cell Signal       Date:  2013-05-21       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.